Insight on Structural Modification, Cytotoxic or Anti-Proliferative Activity, Structure-Activity Relationship of Berberine Derivatives
- 1 November 2023
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Medicinal Chemistry
- Vol. 19 (9) , 823-837
Abstract
: Berberine (BBR) is a quaternary ammonium alkaloid isolated from the Traditional Chinese Medicine Coptis chinensis. It possesses a plethora of pharmacological activities because its unique structure properties make it readily interact with macromolecules through π-π stacking and electrostatic interaction. Its anti-tumor effects are receiving more and more attention in recent years. Cytotoxicity and anti-proliferation are the important anti-tumor modes of BBR, which have been studied by many research groups. : This study aims to review the structural modifications of BBR and its cytotoxic derivatives. Also, to study the corresponding structure-activity relationship. BBR showed potential activities toward tumor cells, however, its modest activity and poor physicochemical properties hindered its application in clinical. Structural modification is a common and effective approach to improve BBR's cytotoxic or anti-proliferative activities. : The structural modifications of BBR, the cytotoxic or anti-proliferative activities of its derivatives, and the corresponding structure-activity relationship (SAR) were summarized in the review. : The concluded SAR of BBR derivatives with their cytotoxic or anti-proliferative activities will provide great prospects for the future anti-tumor drug design with BBR as the lead compound.Keywords
Funding Information
- National Natural Science Foundation of China (21502142, 82074280, 81873083)
This publication has 84 references indexed in Scilit:
- Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell GrowthPLOS ONE, 2013
- Synthesis and Cytotoxicity Evaluation of 13-n-Alkyl Berberine and Palmatine Analogues as Anticancer AgentsMolecules, 2012
- Berberine possesses muscarinic agonist-like properties in cultured rodent cardiomyocytesPharmacological Research, 2011
- Cellular resistance to a nitric oxide releasing glutathione S-transferase P-activated prodrug, PABA/NOInvestigational New Drugs, 2010
- The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesisOncogene, 2007
- Inhibition of DNA Topoisomerase I by Natural and Synthetic Mono‐ and Dimeric Protoberberine AlkaloidsChemistry & Biodiversity, 2007
- The role of nitric oxide in tumour progressionNature Reviews Cancer, 2006
- ROS and protein oxidation in early stages of cytotoxic drug induced apoptosisFree Radical Research, 2006
- Biologic and therapeutic role of HER2 in cancerOncogene, 2003
- Crystal structure of parallel quadruplexes from human telomeric DNANature, 2002